Germany's Rhön-Klinikum Q1 revenue up slightly;  outlook uncertain due to regulatory reforms

Rhoen Klinikum AG

07/05/2026 19:51

Overview

Germany healthcare provider's Q1 revenue rose slightly yr/yr to EUR 436.1 mln

Q1 EBITDA and net income increased from prior year

Company warns 2026 outlook faces significant regulatory and economic uncertainties

Outlook

Company expects 2026 revenue of EUR 1.7 bln, plus or minus 5%

Company forecasts 2026 EBITDA between EUR 110 mln and EUR 125 mln

Company says 2026 outlook subject to significant uncertainty due to regulatory reforms

Result Drivers

PATIENT VOLUME - Number of patients treated increased by 7.4% yr/yr, supporting revenue growth

BUSINESS INTEGRATION - Integration of Ortho Centrum Saale MVZ GmbH contributed to consolidated results

CARE STRUCTURE OPTIMISATION - Group continued to optimise outpatient and inpatient care structures

Company press release: ID:nEQ7G2nG4a

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
EUR 436.10 mln
Q1 Net Income
EUR 13.10 mln
Q1 EBITDA
EUR 30.20 mln


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy."

Wall Street's median 12-month price target for Rhoen Klinikum AG is €14.00, about 8.5% above its May 7 closing price of €12.90

The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 17 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)